Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Fanti, P.
Right arrow Articles by Franke, A. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fanti, P.
Right arrow Articles by Franke, A. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2003) 18: 1862-1868
© 2003 European Renal Association-European Dialysis and Transplant Association

Serum isoflavones and soya food intake in Japanese, Thai and American end-stage renal disease patients on chronic haemodialysis

Paolo Fanti1, Tammy J. Stephenson1, Ismo M. Kaariainen1, Butros Rezkalla1, Yusuke Tsukamoto2, Tetsuo Morishita2, Masanori Nomura2, Chagriya Kitiyakara3, Laurie J. Custer4 and Adrian A. Franke4

1 University of Kentucky Medical Center, Lexington, KY, USA, 2 Morishita Memorial Hospital, Kanagawa, Japan, 3 Ramathibodi Hospital, Bangkok, Thailand and 4 University of Hawaii, Honolulu, HI, USA

Correspondence and offprint requests to: Paolo Fanti, MD, Division of Nephrology, Bone and Mineral Metabolism, University of Kentucky Medical Center, Room MN 564, Lexington, KY 40536, USA. Email: pfanti0{at}pop.uky.edu

Background. Soya foods, a staple in several Asian countries, have received increasing attention because of their nutritional properties and their high isoflavone content. We have shown recently abnormal pharmacokinetics of soya isoflavones following acute oral intake, in soya-naive end-stage renal disease (ESRD) patients. No information is available, however, about blood levels of soya isoflavones in ESRD patients with habitual soya intake. Additionally, no information is available about the conjugation profile of these compounds in ESRD patients.

Methods. To assess the relationship between habitual soya intake on blood isoflavone levels in ESRD patients, we recorded dietary soya food intake and analysed circulating levels of soya isoflavones in randomly selected, clinically stable haemodialysis patients from the United States (n = 20), Thailand (n = 17) and Japan (n = 20). Dietary records and three weekly blood samples were collected from each participant. Combined isoflavones and individual genistein, daidzein, glycitein and O-desmethylangolensin (DMA) were analysed in serum by liquid chromatography/mass spectrometry. Lipid phase micronutrients, including tocopherols, carotenoids and retinol were also measured to compare ethnic differences in isoflavones with those of more common lipid soluble antioxidant micronutrients.

Results. Soya intake was higher in Japanese than in Thai patients and it was negligible in the US patients. Blood levels of genistein were very elevated and significantly higher in the Japanese patients (1128 ± 205 nM), as compared with the Thai and US patients (258 ± 64 and 168 ± 49 nM, respectively; P < 0.001). The other isoflavones followed the same trend. Daidzein was more concentrated than genistein in the dialysis patients. Robust correlation was present between weekly soya intake and blood isoflavone levels (r = 0.56, P < 0.001). Despite very high total isoflavone concentrations, the levels of unconjugated and sulphated isoflavones in the Japanese patients were comparable to those described in healthy subjects. Compared with the striking difference in isoflavones, more easily accessible dietary antioxidants, including tocopherols, carotenoids and retinol, differed only minimally or not at all in the three groups.

Conclusions. ESRD patients appear to accumulate isoflavones as a function of dietary soya intake, resulting in blood concentrations that are higher than those reported in subjects with preserved kidney function. Even in the presence of very elevated total isoflavone levels, the concentrations of the unconjugated and sulphated fractions are comparable to those of healthy subjects. A discrepancy is noted between accumulation of soya isoflavones and other more common lipid-soluble antioxidant micronutrients.

Keywords: diet; genistein; phytochemicals; soya; uraemia


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
A. A Franke, B. M Halm, L. J Custer, Y. Tatsumura, and S. Hebshi
Isoflavones in breastfed infants after mothers consume soy.
Am. J. Clinical Nutrition, August 1, 2006; 84(2): 406 - 413.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
P. Fanti, R. Asmis, T. J. Stephenson, B. P. Sawaya, and A. A. Franke
Positive effect of dietary soy in ESRD patients with systemic inflammation--correlation between blood levels of the soy isoflavones and the acute-phase reactants
Nephrol. Dial. Transplant., August 1, 2006; 21(8): 2239 - 2246.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.